Synthomer (LON:SYNT) Reaches New 52-Week Low – Should You Sell?

Synthomer plc (LON:SYNTGet Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 128 ($1.58) and last traded at GBX 140.20 ($1.73), with a volume of 598533 shares changing hands. The stock had previously closed at GBX 131 ($1.62).

Analysts Set New Price Targets

A number of analysts have weighed in on SYNT shares. Canaccord Genuity Group decreased their target price on shares of Synthomer from GBX 300 ($3.71) to GBX 275 ($3.40) and set a “buy” rating on the stock in a research note on Friday, October 4th. Berenberg Bank cut their price target on Synthomer from GBX 265 ($3.27) to GBX 230 ($2.84) and set a “buy” rating on the stock in a research note on Monday, January 6th.

Check Out Our Latest Analysis on Synthomer

Synthomer Stock Performance

The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 77.42. The company’s 50-day moving average is GBX 157.94 and its two-hundred day moving average is GBX 199.73. The firm has a market cap of £229.33 million, a P/E ratio of -229.84, a PEG ratio of -0.17 and a beta of 1.79.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

See Also

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.